Hohmann Erik, Keough Natalie, Frank Rachel M, Rodeo Scott A
Medical School, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Department of Orthopaedic Surgery and Sports Medicine, Burjeel Hospital for Advanced Surgery, Dubai, United Arab Emirates.
Am J Sports Med. 2025 Mar;53(4):988-998. doi: 10.1177/03635465241249940. Epub 2025 Jan 3.
Microfragmented adipose tissue has been proposed for intra-articular treatment of knee osteoarthritis. There are little data comparing the outcomes of treatment between microfragmented adipose tissue and other biological treatments.
To perform a systematic review and meta-analysis comparing microfragmented aspirated fat injections to other orthobiologics, hyaluronic acid, and corticosteroid injections for symptomatic knee osteoarthritis.
Systematic review and meta-analysis; Level of evidence, 2.
A systematic review of the literature was performed to identify pertinent publications in the MEDLINE, Embase, Scopus, and Google Scholar databases, including all level 1 to 3 studies from 2000 to 2023. Validated knee scores (visual analog scale [VAS] for pain, Knee injury and Osteoarthritis Outcome Score [KOOS], Lysholm, International Knee Documentation Committee) were included as outcome measures. Risk of bias was assessed using Cochrane tools. The Grading of Recommendations Assessment, Development and Evaluation system was used to assess the quality of the body of evidence and the modified Coleman Methodology Score was used to assess study quality. Heterogeneity was assessed using χ and statistics.
Five studies were included in the analysis. One study had a high risk of bias; 4 studies had some risk of bias. The overall study quality was fair, and the certainty of evidence was low. The pooled estimate for VAS scores did not demonstrate significant differences at 3, 6, and 12 months. The pooled estimate for the KOOS Pain, Symptoms, Activities of Daily Living, Sport and Recreation, and Quality of Life subscales did not demonstrate significant differences at 3, 6, and 12 months.
The results of this systematic review and meta-analysis demonstrated that there were no statistically significant differences for both the clinical outcomes and pain scores between microfragmented adipose tissue and other orthobiologics for the treatment of knee osteoarthritis. However, modest study quality, some risk of bias, and low certainty of evidence reduce external validity, and these results must be viewed with some caution.
微片段化脂肪组织已被提议用于膝关节骨关节炎的关节内治疗。比较微片段化脂肪组织与其他生物治疗效果的数据很少。
进行一项系统评价和荟萃分析,比较微片段化抽吸脂肪注射与其他骨科生物制剂、透明质酸和皮质类固醇注射治疗症状性膝关节骨关节炎的效果。
系统评价和荟萃分析;证据等级,2级。
对文献进行系统评价,以确定MEDLINE、Embase、Scopus和谷歌学术数据库中的相关出版物,包括2000年至2023年的所有1至3级研究。将经过验证的膝关节评分(疼痛视觉模拟量表[VAS]、膝关节损伤和骨关节炎结局评分[KOOS]、Lysholm评分、国际膝关节文献委员会评分)作为结局指标。使用Cochrane工具评估偏倚风险。推荐评估、制定和评价系统用于评估证据体的质量,改良的科尔曼方法评分用于评估研究质量。使用χ²和I²统计量评估异质性。
五项研究纳入分析。一项研究存在高偏倚风险;四项研究存在一些偏倚风险。总体研究质量一般,证据确定性较低。VAS评分的合并估计在3、6和12个月时未显示出显著差异。KOOS疼痛、症状、日常生活活动、运动和娱乐以及生活质量子量表的合并估计在3、6和12个月时未显示出显著差异。
这项系统评价和荟萃分析的结果表明,在治疗膝关节骨关节炎方面,微片段化脂肪组织与其他骨科生物制剂在临床结局和疼痛评分上均无统计学显著差异。然而,研究质量一般、存在一些偏倚风险以及证据确定性较低降低了外部有效性,这些结果必须谨慎看待。